30977266|t|Hyperammonemia after capecitabine associated with occult impairment of the urea cycle.
30977266|a|BACKGROUND: Cancer patients receiving chemotherapy often complain of "chemobrain" or cognitive impairment, but mechanisms remain elusive. METHODS: A patient with gastric cancer developed delirium and hyperammonemia after chemotherapy with the 5-fluorouracil pro-drug capecitabine. Exome sequencing facilitated a search for mutations among 43 genes associated with hyperammonemia and affecting the urea cycle directly or indirectly. RESULTS: The patient's urea cycle was impaired by capecitabine-induced liver steatosis, and portosystemic shunting of gut ammonia into the systemic circulation. The patient was also heterozygous for amino acid substitution mutations previously reported to create dysfunctional proteins in 2 genes, ORNT2 (ornithine transporter-2 for the urea cycle), and ETFA (electron transport flavoprotein alpha for fatty acid oxidation). The mutations explained the patient's abnormal plasma amino acid profile and exaggerated response to allopurinol challenge. Global population variations among the 43 hyperammonemia genes were assessed for inactivating mutations, and for amino acid substitutions predicted to be deleterious by complementary algorithms, SIFT and PolyPhen-2. One or 2 deleterious mutations occur among the 43 genes in 13.9% and 1% of individuals, respectively. CONCLUSIONS: Capecitabine and 5-fluorouracil inhibit pyrimidine biosynthesis, decreasing ammonia utilization. These drugs can induce hyperammonemia in susceptible individuals. The risk factors of hyperammonemia, gene mutations and liver dysfunction, are not rare. Diagnosis will trigger appropriate treatment and ameliorate brain toxicity.
30977266	0	14	Hyperammonemia	Disease	MESH:D022124
30977266	21	33	capecitabine	Chemical	MESH:D000069287
30977266	75	79	urea	Chemical	MESH:D014508
30977266	99	105	Cancer	Disease	MESH:D009369
30977266	106	114	patients	Species	9606
30977266	172	192	cognitive impairment	Disease	MESH:D003072
30977266	236	243	patient	Species	9606
30977266	249	263	gastric cancer	Disease	MESH:D013274
30977266	274	282	delirium	Disease	MESH:D003693
30977266	287	301	hyperammonemia	Disease	MESH:D022124
30977266	330	344	5-fluorouracil	Chemical	MESH:D005472
30977266	354	366	capecitabine	Chemical	MESH:D000069287
30977266	451	465	hyperammonemia	Disease	MESH:D022124
30977266	484	488	urea	Chemical	MESH:D014508
30977266	532	539	patient	Species	9606
30977266	542	546	urea	Chemical	MESH:D014508
30977266	569	581	capecitabine	Chemical	MESH:D000069287
30977266	590	605	liver steatosis	Disease	MESH:D005234
30977266	641	648	ammonia	Chemical	MESH:D000641
30977266	684	691	patient	Species	9606
30977266	817	822	ORNT2	Gene	83884
30977266	856	860	urea	Chemical	MESH:D014508
30977266	873	877	ETFA	Gene	2108
30977266	921	931	fatty acid	Chemical	MESH:D005227
30977266	972	979	patient	Species	9606
30977266	1045	1056	allopurinol	Chemical	MESH:D000493
30977266	1110	1124	hyperammonemia	Disease	MESH:D022124
30977266	1399	1411	Capecitabine	Chemical	MESH:D000069287
30977266	1416	1430	5-fluorouracil	Chemical	MESH:D005472
30977266	1439	1449	pyrimidine	Chemical	MESH:C030986
30977266	1475	1482	ammonia	Chemical	MESH:D000641
30977266	1519	1533	hyperammonemia	Disease	MESH:D022124
30977266	1582	1596	hyperammonemia	Disease	MESH:D022124
30977266	1617	1634	liver dysfunction	Disease	MESH:D017093
30977266	1710	1724	brain toxicity	Disease	MESH:D001927
30977266	Negative_Correlation	MESH:D005472	MESH:D013274
30977266	Negative_Correlation	MESH:C030986	MESH:D000069287
30977266	Association	MESH:D014508	83884
30977266	Positive_Correlation	MESH:D000069287	MESH:D003693
30977266	Negative_Correlation	MESH:D000641	MESH:D005472
30977266	Negative_Correlation	MESH:D000069287	MESH:D000641
30977266	Negative_Correlation	MESH:D000069287	MESH:D013274
30977266	Association	MESH:D014508	MESH:D005234
30977266	Association	MESH:D022124	83884
30977266	Association	MESH:D017093	83884
30977266	Positive_Correlation	MESH:D005472	MESH:D022124
30977266	Positive_Correlation	MESH:D000069287	MESH:D022124
30977266	Negative_Correlation	MESH:C030986	MESH:D005472
30977266	Positive_Correlation	MESH:D000069287	MESH:D005234
30977266	Association	MESH:D014508	MESH:D022124
30977266	Association	MESH:D005227	2108
30977266	Positive_Correlation	MESH:D005472	MESH:D003693
30977266	Association	MESH:D000069287	MESH:D014508

